Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:11 AM
Ignite Modification Date:
2025-12-25 @ 4:11 AM
NCT ID:
NCT00451620
Eligibility Criteria:
Inclusion Criteria:
* Type 2 diabetes \> 3 months duration
* Male or female
* Over 65 years of age
* Diet controlled only
* HgbA1C \< 8.5%
Exclusion Criteria:
* Treatment with oral hypoglycemic agents or insulin or the likelihood of requiring treatment with these during the study.
* Anemia - hgb below 130 g/L (males) and below 120 g/L (females).
* Taking medications that known to interfere with glucose metabolism eg systemic corticosteriods, non-selective beta blockers.
* Known or suspected allergy to glyburide, sulfa drugs or GlucoNorm impaired liver function, as shown by but not limited to AST and/or ALT \> 2x the upper limit of normal.
* Impaired renal function, as shown by but not limited to serum creatinine \> 133 µmol/L (males) or 124 µmol/L (females).
* Participated in another clinical trial within the past 30 days.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
65 Years
Study:
NCT00451620
Study Brief:
Protocol Section:
NCT00451620